MedPath logo

Xolair 150mg Powder and Solvent for Solution for Injection

Prescription Only
Drug type: Therapeutic
ATC code: R03DX05
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route of administration: SUBCUTANEOUS
Active ingredient: Omalizumab
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Approval Date
2006-07-07
Approval Number
SIN13212P
Manufacturer
Takeda Austria GmbH Novartis Pharma Stein AG DELPHARM DIJON - QUETIGNY
Package Insert
pdf icon
Xolair PI.pdf
View